The vaginal microbiota and susceptibility to HIV

AIDS

Volumn 28, Issue 16, 2014, Pages 2333-2344

  Buvé, Anne ^a   Jespers, Vicky ^a   Crucitti, Tania ^a   Fichorova, Raina N ^b,c  

^a INSTITUTE OF TROPICAL MEDICINE   (Belgium)

^b Laboratory or Genital Tract Biology Department of Obstetrics Gynecology and Reproductive Biology   (United States)

^c BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

Bacterial vaginosis; HIV transmission; Intermediate flora; Vaginal microbiome

Indexed keywords

BLACK PERSON; ETHNIC DIFFERENCE; FEMALE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; INFECTION SENSITIVITY; POPULATION; PREVALENCE; REVIEW; RISK FACTOR; SEXUALLY TRANSMITTED DISEASE; VAGINA FLORA; VAGINITIS; COMPLICATION; DISEASE PREDISPOSITION; HIV INFECTIONS; IMMUNOLOGY; MALE; MICROBIOLOGY; MICROFLORA; RISK ASSESSMENT; TRANSMISSION; VAGINA;

DISEASE SUSCEPTIBILITY; FEMALE; HIV INFECTIONS; HUMANS; MALE; MICROBIOTA; RISK ASSESSMENT; VAGINA; VAGINOSIS, BACTERIAL;

EID: 84916233345     PISSN: 02699370     EISSN: 14735571     Source Type: Journal    
DOI: 10.1097/QAD.0000000000000432     Document Type: Review

References (144)

1. Buvé A, Caraël M, Hayes RJ, Auvert B, Ferry B, Robinson NJ, et al. Multicentre study on factors determining differences in rate of spread of HIV in sub-Saharan Africa: summary and conclusions. AIDS (Suppl 4): 2001:S127-S131.
2. Pettifor AE, Levandowski BA, Macphail C, Miller WC, Tabor J, Ford C, et al. A tale of two countries: rethinking sexual risk for HIV among young people in South Africa and the United States. J Adolesc Health 2011;49:237-243.
3. Powers KA, Poole C, Pettifor AE, Cohen MS. Rethinking the heterosexual infectivity of HIV-1: a systematic review and meta-analysis. Lancet Infect Dis 2008;8:553-563.
4. Boily M-C, Baggaley RF, Wang L, Masse B, White RG, Hayes RJ, et al. Heterosexual risk of HIV-1 infection per sexual act: systematic review and meta-analysis of observational studies. Lancet Infect Dis 2009;9:118-129.
5. Ravel J, Gajer P, Abdo Z, Schneider GM, Koenig SS, McCulle SL, et al. Vaginal microbiome of reproductive-age women. Proc Natl Acad Sci U S A 2011;108(Suppl 1):4680-4687.
6. Zhou X, Brown CJ, Abdo Z, Davis CC, Hansmann MA, Joyce P, et al. Differences in the composition of vaginal microbial communities found in healthy Caucasian and black women. ISME J 2007;1:121-133.
7. Srinivasan S, Liu C, Mitchell CM, Fiedler TL, Thomas KK, Agnew KJ, et al. Temporal variability of human vaginal bacteria and relationshipwithbacterial vaginosis. PLoSOne 2010;5:e10197.
8. Santiago GL, Cools P, Verstraelen H, Trog M, Missine G, El Aila N, et al. Longitudinal study of the dynamics of vaginal microflora during two consecutive menstrual cycles. PLoS One 2011;6:e28180.
9. Jespers V, Menten J, Smet H, Poradosú S, Abdellati S, Verhelst R, et al. Quantification of bacterial species of the vaginal microbiome in different groups of women, using nucleic acid amplification tests. BMC Microbiol 2012;12:83.
10. Hillier SL, Lau RJ. Vaginal microflora in postmenopausal women who have not received estrogen replacement therapy. Clin Infect Dis 1997;25(Suppl 2):S123-S126.
11. Amsel R, Totten PA, Spiegel CA, Chen KC, Eschenbach D, Holmes KK. Nonspecific vaginitis. Diagnostic criteria and microbial and epidemiologic associations. Am J Med 1983;74:14-22.
12. Nugent RP, Krohn MA, Hillier SL. Reliability of diagnosing bacterial vaginosis is improved by a standardized method of gram stain interpretation. J Clin Microbiol 1991;29:297-301.
13. Hillier SL, Krohn MA, Nugent RP, Gibbs RS, Vaginal Infections and Prematurity Study Group. Characteristics of three vaginal flora patterns assessedby gram stain among pregnant women. Am J Obstet Gynecol 1992;166:938-944.
14. Ling Z, Liu X, Chen X, Zhu H, Nelson KE, Xia Y, et al. Diversity of cervicovaginal microbiota associated with female lower genital tract infections. Microb Ecol 2011;61:704-714.
15. Pépin J, Deslandes S, Giroux G, Sobéla F, Khonde N, Diakité S, et al. The complex vaginal flora of West African women with bacterial vaginosis. PLoS One 2011;6:e25082.
16. Verhelst R, Verstraelen H, Claeys G, Verschraegen G, Delanghe J, Van Simaey L, et al. Cloning of 16S rRNA genes amplified from normal and disturbed vaginal microflora suggests a strong association between Atopobium vaginae, Gardnerella vaginalis and bacterial vaginosis. BMC Microbiol 2004;4:16.
17. Menard JP, Fenollar F, Henry M, Bretelle F, Raoult D. Molecular quantification of Gardnerella vaginalis and Atopobium vaginae loads to predict bacterial vaginosis. Clin Infect Dis 2008;47:33-43.
18. Haggerty CL, Totten PA, Ferris M, Martin DH, Hoferka S, Astete SG, et al. Clinical characteristics of bacterial vaginosis among women testing positive for fastidious bacteria. Sex Transm Infect 2009;85:242-248.
19. Marrazzo JM. Interpreting the epidemiology and natural history of bacterial vaginosis: are we still confused? Anaerobe 2011;17:186-190.
20. Schwebke JR, Muzny CA, Josey WE. Role of Gardnerella vaginalis in the pathogenesis of bacterial vaginosis: a conceptual model. J Infect Dis 2014 [Epub ahead of print].
21. Schwebke JR, Flynn MS, Rivers CA. Prevalence of Gardnerella vaginalis among women with lactobacillus-predominant vaginal flora. Sex Transm Infect 2014;90:61-63.
22. Hickey RJ, Forney LJ. Role of Gardnerella vaginalis in the pathogenesis of bacterial vaginosis (letter). J Infect Dis 2014 [Epub ahead of print].
23. Ma B, Forney LJ, Ravel J. Vaginal microbiome: rethinking health and disease. Annu Rev Microbiol 2012;66:371-389.
24. Witkin SS, Linhares IM, Giraldo P. Bacterial flora of the female genital tract: function and immune regulation. Best Pract Res Clin Obstet Gynaecol 2007;21:347-354.
25. Cadieux PA, Burton J, Devillard E, Reid G. Lactobacillus by products inhibit the growth and virulence of uropathogenic Escherichia coli. J Physiol Pharmacol 2009;60(Suppl 6):13-18.
26. Kalyoussef S, Nieves E, Dinerman E, Carpenter C, Shankar V, Oh J, et al. Lactobacillus proteins are associated with the bactericidal activity against E. coli of female genital tract secretions. PLoS One 2012;7:e49506.
27. Zarate G, Nader-Macias ME. Influence of probiotic vaginal lactobacilli on in vitro adhesion of urogenital pathogens to vaginal epithelial cells. Lett Appl Microbiol 2006;43:174-180.
28. Schwebke JR. Role of vaginal flora as a barrier to HIV acquisition. Curr Infect Dis Rep 2001;3:152-155.
29. Klebanoff SJ, Coombs RW. Viricidal effect of Lactobacillus acidophiluson human immunodeficiency virus type1: possible role in heterosexual transmission. J Exp Med 1991;174:289-292.
30. O'Hanlon DE, Moench TR, Cone RA. In vaginalfluid, bacteria associated with bacterial vaginosis can be suppressed with lactic acid but not hydrogen peroxide. BMC Infect Dis 2011;11:200.
31. O'Hanlon DE, Lanier BR, Moench TR, Cone RA. Cervicovaginal fluid and semen block the microbicidal activity of hydrogen peroxide produced by vaginal lactobacilli. BMC Infect Dis 2010;10:120.
32. Aldunate M, Tyssen D, Johnson A, Zakir T, Sonza S, Moench T, et al. Vaginal concentrations of lactic acid potently inactivate HIV. J Antimicrob Chemother 2013;68:2015-2025.
33. O'Hanlon DE, Moench TR, Cone RA. Vaginal pH and microbicidal lactic acid when lactobacilli dominate the microbiota. PLoS One 2013;8:e80074.
34. Witkin SS, Mendes-Soares H, Linhares IM, Jayaram A, Ledger WJ, Forney LJ. Influence of vaginal bacteria and D- and L-lactic acid isomers on vaginal extracellular matrix metalloproteinase inducer: implications for protection against upper genital tract infections. MBio; 4:e00460-13.
35. Witkin SS, Alvi S, Bongiovanni AM, Linhares IM, Ledger WJ. Lactic acid stimulates interleukin-23 production by peripheral blood mononuclear cells exposed to bacterial lipopolysaccharide. FEMS Immunol Med Microbiol 2011;61:153-158.
36. Mossop H, Linhares IM, Bongiovanni AM, Ledger WJ, Witkin SS. Influence of lactic acid on endogenous and viral RNA-induced immune mediator production by vaginal epithelial cells. Obstet Gynecol 2011;118:840-846.
37. Zeuthen LH, Fink LN, Frokiaer H. Epithelial cells prime the immune response to an array of gut-derived commensals towards a tolerogenic phenotype through distinct actions of thymic stromal lymphopoietin and transforming growth factor-beta. Immunology 2008;123:197-208.
38. Donato KA, Gareau MG, Wang Y J J, Sherman PM. Lactobacillus rhamnosus GG attenuates interferon-{gamma} and tumor necrosis factor-{alpha}-induced barrier dysfunction and pro-inflammatory signalling. Microbiology 2010;156(Pt 11):3288-3297.
39. Neish AS, Gewirtz AT, Zeng H, Young AN, Hobert ME, Karmali V, et al. Prokaryotic regulation of epithelial responses by inhibition of IkappaB-alpha ubiquitination. Science 2000;289:1560-1563.
40. Novak RM, Donoval BA, Graham PJ, Boksa LA, Spear G, Hershow RC, et al. Cervicovaginal levels of lactoferrin, secretory leukocyte protease inhibitor, and RANTES and the effects of coexisting vaginoses in human immunodeficiency virus (HIV)-seronegative women with a high risk of heterosexual acquisition of HIV infection. Clin Vaccine Immunol 2007;14:1102-1107.
41. Hedges SR, Barrientes F, Desmond RA, Schwebke JR. Local and systemic cytokine levels in relation to changes in vaginal flora. J Infect Dis 2006;193:556-562.
42. Fichorova RN, Lai JJ, Schwartz JL, Weiner DH, Mauck CK, Callahan MM. Baseline variation and associations between subject characteristics and five cytokine biomarkers of vaginal safety among healthy nonpregnant women in microbicide trials. Cytokine 2011;55:134-140.
43. Libby EK, Pascal KE, Mordechai E, Adelson ME, Trama JP. Atopobium vaginae triggers an innate immune response in an in vitro model of bacterial vaginosis. Microbes Infect 2008;10:439-446.
44. Yamamoto HS, Xu Q, Fichorova RN. Homeostatic properties of Lactobacillus jensenii engineered as a live vaginal anti-HIV microbicide. BMC Microbiol 2013;13:4.
45. Fichorova RN, Buck OR, Yamamoto HS, Fashemi T, Dawood HY, Fashemi B, et al. The villain team-up or how Trichomonas vaginalis and bacterial vaginosis alter innate immunity in concert. Sex Transm Infect 2013;89:460-466.
46. Fashemi B, Delaney ML, Onderdonk AB, Fichorova RN. Effects of feminine hygiene products on the vaginal mucosal biome. Microb Ecol Health Dis 2013;24:19703 - http://dx.doi.org/10.3402/mehd.v24i0.19703.
47. Fichorova RN, Yamamoto HS, Delaney ML, Onderdonk AB, Doncel GF. Novel vaginal microflora colonization model providing new insight into microbicide mechanism of action. MBio 2011;2:e00168-00111.
48. Hladik F, McElrath MJ. Setting the stage: host invasion by HIV. Nat Rev Immunol 2008;8:447-457.
49. Alfano M, Poli G. The cytokine network in HIV infection. Curr Mol Med 2002;2:677-689.
50. Shattock RJ, Haynes BF, Pulendran B, Flores J, Esparza J. Improving defences at the portal of HIV entry: mucosal and innate Immunity. PLoS Med 2008;5:e81.
51. Genç MR, Delaney ML, Onderdonk AB, Witkin SS, Microbiology and Prematurity (MAP) Study Group. Vaginal nitric oxide in pregnant women with bacterial vaginosis. Am J Reprod Immunol 2006;56:86-90.
52. Bogdan C. Nitric oxide and the immune response. Nat Immunol 2001;2:907-916.
53. Valore EV, Wiley DJ, Ganz T. Reversible deficiency of antimicrobial polypeptides in bacterial vaginosis. Infect Immun 2006;74:5693-5702.
54. McNeely TB, Shugars DC, Rosendahl M, Tucker C, Eisenberg SP, Wahl SM. Inhibition of human immunodeficiency virus type 1 infectivity by secretory leukocyte protease inhibitor occurs prior to viral reverse transcription. Blood 1997;90:1141-1149.
55. Draper DL, Landers DV, Krohn MA, Hillier SL, Wiesenfeld HC, Heine RP. Levels of vaginal secretory leukocyte protease inhibitor are decreased in women with lower reproductive tract infections. Am J Obstet Gynecol 2000;183:1243-1248.
56. Huppert JS, Huang B, Chen C, Dawood HY, Fichorova RN. Clinical evidence for the role of Trichomonas vaginalis in regulation of secretory leukocyte protease inhibitor in the female genital tract. J Infect Dis 2013;207:1462-1470.
57. Morrison C, Fichorova R, Mauck C, Chen P-L, Kwok C, Chipato T, et al. Cervical inflammation and immunity associated with hormonal contraception, pregnancy and HIV-1 seroconversion. J AIDS 2014;66:109-117.
58. Atashili J, Poole C, Ndumbe PM, Adimora AA, Smith JS. Bacterial vaginosis and HIV acquisition: a meta-analysis of published studies. AIDS 2008;22:1493-1501.
59. Low N, Chersich MF, Schmidlin K, Egger M, Francis SC, van de Wijgert JH, et al. Intravaginal practices, bacterial vaginosis, and HIV infection in women: individual participant data meta-analysis. PLoS Med 2011;8:e1000416.
60. Kapiga SH, Sam NE, Bang H, Ni Q, Ao TT, Kiwelu I, et al. The role of herpes simplex virus type 2 and other genital infections in the acquisition of HIV-1 among high-risk women in northern Tanzania. J Infect Dis 2007;195:1260-1269.
61. Van de Wijgert J H H M, Morrison CS, Brown J, Kwok C, Van Der Pol B, Chipato T, et al. Disentangling contributions of reproductive tract infections to HIV acquisition in African women. Sex Transm Dis 2009;36:357-364.
62. Reid SE, Dai JY, Wang J, Sichalwe BN, Akpomiemie G, Cowan FM, et al. Pregnancy, contraceptive use, and HIV acquisition in HPTN 039: relevance for HIV prevention trials among African women. J Acquir Immune Defic Syndr 2010;53:606-613.
63. Cherpes TL, Meyn LA, Krohn MA, Lurie JG, Hillier SL. Association between acquisition of herpes simplex virus type 2 in women and bacterial vaginosis. Clin Infect Dis 2003;37:319-325.
64. Gallo MF, Warner L, Macaluso M, Stone KM, Brill I, Fleenor ME, et al. Risk factors for incident herpes simplex type 2 virus infection among women attending a sexually transmitted disease clinic. Sex Transm Dis 2008;35:679-685.
65. Chohan V, Baeten JM, Benki S, Graham SM, Lavreys L, Mandaliya K, et al. A prospective study of risk factors for herpes simplex virus type 2 acquisition among high-risk HIV-1 seronegative women in Kenya. Sex Transm Infect 2009;85:489-492.
66. Rathod SD, Krupp K, Klausner JD, Arun A, Reingold AL, Madhivanan P. Bacterial vaginosis and risk for Trichomonas vaginalis infection: a longitudinal analysis. Sex Transm Dis 2011;38:882-886.
67. Brotman RM, Klebanoff MA, Nansel TR, Yu KF, Andrews WW, Zhang J, Schwebke JR. Bacterial vaginosis assessed by gram stain and diminished colonization resistance to incident gonococcal, chlamydial, and trichomonal genital infection. J Infect Dis 2010;202:1907-1915.
68. Balkus JE, Richardson BA, Rabe LK, Taha TE, Mgodi N, Kasaro MP, et al. Bacterial vaginosis and the risk of Trichomonas vaginalis acquisition among HIV-1-negative women. Sex Transm Dis 2014;41:123-128.
69. Watts DH, Fazzari M, Minkoff H, Hillier SL, Sha B, Glesby M, et al. Effects of bacterial vaginosis and other genital infections on the natural history of human papillomavirus infection in HIV-1-infected and high-risk HIV-1-uninfected women. J Infect Dis 2005;191:1129-1139.
70. King CC, Jamieson DJ, Wiener J, Cu-Uvin S, Klein RS, Rompalo AM, et al. Bacterial vaginosis and the natural history of human papillomavirus. Infect Dis Obstet Gynecol 2011;2011:doi:10.1155/2011/319460.
71. Glynn JR, Biraro S, Weiss HA. Herpes simplex virus type 2: a key role in HIV incidence. AIDS 2009;23:1595-1598.
72. Cohen CR, Lingappa JR, Baeten JM, Ngayo MO, Spiegel CA, Hong T, et al. Bacterial vaginosis associated with Increased risk of female-to-male HIV-1 transmission: a prospective cohort analysis among African couples. PLoS Med 2012;9:e1001251.
73. Low AJ, Konate I, Nagot N, Weiss HA, Kania D, Vickerman P, et al. Cervicovaginal HIV-1 shedding in women taking antiretroviral therapy in Burkina Faso: a longitudinal study. J Acquir Immune Defic Syndr 2014;65:237-245.
74. Kenyon C, Colebunders R, Crucitti T. The global epidemiology of bacterial vaginosis: a systematic review. Am J Obstet Gynecol 2013;209:505-523.
75. Koumans EH, Sternberg M, Bruce C, McQuillan G, Kendrick J, Sutton M, et al. The prevalence of bacterial vaginosis in the United States, 2001-2004; associations with symptoms, sexual behaviors, and reproductive health. Sex Transm Dis 2007;34:864-869.
76. de Lima Soares V, de Mesquita AM, Cavalcante FG, Silva ZP, Hora V, Diedrich T, et al. Sexually transmitted infections in a female population in rural north-east Brazil: prevalence, morbidity and risk factors. Trop Med Int Health 2003;8:595-603.
77. Miranda AE, Merçon-de-Vargas PR, Corbett CE, Corbett JF, Dietze R. Perspectives on sexual and reproductive health among womenin an ancient mining area in Brazil. Rev Panam Salud Publica 2009;25:157-161.
78. Oliveira FA, Pfleger V, Lang K, Heukelbach J, Miralles I, Fraga F, et al. Sexually transmitted infections, bacterial vaginosis, and candidiasis in women of reproductive age in rural Northeast Brazil: a population-based study. Mem Inst Oswaldo Cruz 2007;102:751-756.
79. García PJ, Chavez S, Feringa B, Chiappe M, Li W, Jansen KU, et al. Reproductive tract infections in rural women from the highlands, jungle, and coastal regions of Peru. Bull World Health Organ 2004;82:483-492.
80. Ramia S, Kobeissi L, El Kak F, Shamra S, Kreidieh K, Zurayk H. Reproductive tract infections (RTIs) among married nonpregnant women living in a low-income suburb of Beirut, Lebanon. J Infect Dev Ctries 2012;6:680-683.
81. Eriksson K, Adolfsson A, Forsum U, Larsson PG. The prevalence of BV in the population on the Åland Islands during a 15-year period. APMIS 2010;118:903-908.
82. Datcu R, Gesink D, Mulvad G, Montgomery-Andersen R, Rink E, Koch A, et al. Vaginal microbiome in women from Greenland assessed by microscopy and quantitative PCR. BMC Infect Dis 2013;13:480.
83. Patel V, Weiss HA, Mabey D, West B, D'Souza S, Patil V, et al. The burden and determinants of reproductive tract infections in India: a population based study of women in Goa, India. Sex Transm Infect 2006;82:243-249.
84. Nayab D. Reproductive tract infections among women in Pakistan: an urban case study. Pak Dev Rev 2005;44:131-158.
85. Lan PT, Lundborg CS, Phuc HD, Sihavong A, Unemo M, Chuc NT, et al. Reproductive tract infections including sexually transmitted infections: a population-based study of women of reproductive age in a rural district of Vietnam. Sex Transm Infect 2008;84:126-132.
86. Go VF, Quan VM, Celentano DD, Moulton LH, Zenilman JM. Prevalence and risk factors for reproductive tract infections among women in rural Vietnam. Southeast Asian J Trop Med Public Health 2006;37:185-189.
87. Kirakoya-Samadoulougou F, Nagot N, Defer MC, Yaro S, Fao P, Ilboudo F, et al. Epidemiology of herpes simplex virus type 2 infection in rural and urban Burkina Faso. Sex Transm Dis 2011;38:117-123.
88. Walraven G, Scherf C, West B, Ekpo G, Paine K, Coleman R, et al. The burden of reproductive-organ disease in rural women in The Gambia, West Africa. Lancet 2001;357:1161-1167.
89. Wawer MJ, Sewankambo NK, Serwadda D, Quinn TC, Paxton LA, Kiwanuka N, et al. Control of sexually transmitted diseases for AIDS prevention in Uganda: a randomised community trial. Rakai Project Study Group. Lancet 1999;353:525-535.
90. Goldenberg RL, Klebanoff MA, Nugent R, Krohn MA, Hillier S, Andrews WW. Bacterial colonization of the vagina during pregnancy in four ethnic groups. Vaginal Infections and Prematurity Study Group. Am J Obstet Gynecol 1996;174:1618-1621.
91. Tolosa JE, Chaithongwongwatthana S, Daly S, Maw WW, Gaitán H, Lumbiganon P, et al. The International Infections in Pregnancy (IIP) study: variations in the prevalence of bacterial vaginosis and distribution of morphotypes in vaginal smears among pregnant women. Am J Obstet Gynecol 2006;195:1198-1204.
92. Wenman WM, Tataryn IV, Joffres MR, Pearson R, Grace MG, Albritton WL, et al. Demographic, clinical and microbiological characteristics of maternity patients: a Canadian clinical cohort study. Can J Infect Dis 2002;13:311-318.
93. Gondo F, da Silva MG, Polettini J, Tristao Ada R, Peracoli JC, Witkin SS, et al. Vaginal flora alterations and clinical symptoms in low-risk pregnant women. Gynecol Obstet Invest 2011;71:158-162.
94. Krauss-Silva L, Almada-Horta A, Alves MB, Camacho KG, Moreira ME, Braga A. Basic vaginal pH, bacterial vaginosis and aerobic vaginitis: prevalence in early pregnancy and risk of spontaneous preterm delivery, a prospective study in a low socioeconomic and multiethnic South American population. BMC Pregnancy Childbirth 2014;14:107.
95. Kamara P, Hylton-Kong T, Brathwaite A, Del Rosario GR, Kristensen S, Patrick N, et al. Vaginal infections in pregnant women in Jamaica: prevalence and risk factors. Int J STD AIDS 2000;11:516-520.
96. Desseauve D, Chantrel J, Fruchart A, Khoshnood B, Brabant G, Ancel PY, et al. Prevalence and risk factors of bacterial vaginosis during the first trimester of pregnancy in a large French population-based study. Eur J Obstet Gynecol Reprod Biol 2012;163:30-34.
97. Daskalakis G, Papapanagiotou A, Mesogitis S, Papantoniou N, Mavromatis K, Antsaklis A. Bacterial vaginosis and group B streptococcal colonization and preterm delivery in a low-risk population. Fetal Diagn Ther 2006;21:172-176.
98. Cristiano L, Rampello S, Noris C, Valota V. Bacterial vaginosis: prevalence in an Italian population of asymptomatic pregnant women and diagnostic aspects. Eur J Epidemiol 1996;12:383-390.
99. Gratacós E, Figueras F, Barranco M, Ros R, Andreu A, Alonso PL, et al. Prevalence of bacterial vaginosis and correlation of clinical to Gram stain diagnostic criteria in low risk pregnant women. Eur J Epidemiol 1999;15:913-916.
100. Martínez de Tejada B, Coll O, de Flores M, Hillier SL, Landers DV. [Prevalence of bacterial vaginosis in an obstetric population of Barcelona.]. Med Clin (Barc) 1998;110:201-204 [Article in Spanish].
101. Oakeshott P, Hay P, Hay S, Steinke F, Rink E, Kerry S. Association between bacterial vaginosis or chlamydial infection and miscarriage before 16 weeks' gestation: prospective community based cohort study. Br Med J 2002;325:1334.1.
102. Riduan JM, Hillier SL, Utomo B, Wiknjosastro G, Linnan M, Kandun N. Bacterial vaginosis and prematurity in Indonesia: association in early and late pregnancy. Am J Obstet Gynecol 1993;169:175-178.
103. Thammalangsy S, Sihavong A, Phouthavane T, Sayabounthavong K, Puapermpoonsiri S, Kitayaporn D, et al. The prevalence of lower genital tract infections among ante-natal care (ANC) clinic patients in two central hospitals, Vientiane, Lao People's Democratic Republic. Southeast Asian J Trop Med Public Health 2006;37:190-199.
104. Puapermpoonsiri S, Kato N, Watanabe K, Ueno K, Chongsomchai C, Lumbiganon P. Vaginal microflora associated with bacterial vaginosis in Japanese and Thai pregnant women. Clin Infect Dis 1996;23:748-752.
105. Goto A, Nguyen QV, Pham NM, Kato K, Cao TP, Le TH, et al. Prevalence of and factors associated with reproductive tract infections among pregnant women in ten communes in Nghe An Province, Vietnam. J Epidemiol 2005;15:163-172.
106. Shimano S, Nishikawa A, Sonoda T, Kudo R. Analysis of the prevalence of bacterial vaginosis and Chlamydia trachomatis infection in 6083 pregnant women at a hospital in Otaru, Japan. J Obstet Gynaecol Res 2004;30:230-236.
107. Kirakoya-Samadoulougou F, Nagot N, Defer MC, Yaro S, Meda N, Robert A. Bacterial vaginosis among pregnant women in Burkina Faso. Sex Transm Dis 2008;35:985-989.
108. Blankhart D, Müller O, Gresenguet G, Weis P. Sexually transmitted infections in young pregnant women in Bangui, Central African Republic. Int J STD AIDS 1999;10:609-614.
109. Romoren M, Velauthapillai M, Rahman M, Sundby J, Klouman E, Hjortdahl P. Trichomoniasis and bacterial vaginosis in pregnancy: inadequately managed with the syndromic approach. Bull World Health Organ 2007;85:297-304.
110. Govender L, Hoosen AA, Moodley J, Moodley P, Sturm AW. Bacterial vaginosis and associated infections in pregnancy. Int J Gynaecol Obstet 1996;55:23-28.
111. Frohlich JA, Abdool Karim Q, Mashego MM, Sturm AW, Abdool Karim SS. Opportunities for treating sexually transmitted infections and reducing HIV risk in rural South Africa. J Adv Nurs 2007;60:377-383.
112. Tann CJ, Mpairwe H, Morison L, Nassimu K, Hughes P, Omara M, et al. Lack of effectiveness of syndromic management in targeting vaginal infections in pregnancy in Entebbe, Uganda. Sex Transm Infect 2006;82:285-289.
113. Li XD, Wang CC, Zhang XJ, Gao GP, Tong F, Li X, et al. Risk factors for bacterial vaginosis: results from a cross-sectional study having a sample of 53, 652 women. Eur J Clin Microbiol Infect Dis 2014 Sep; 33(9):1525-32. doi: 10.1007/s10096-014-2103-1.
114. Fethers KA, Fairley CK, Hocking JS, Gurrin LC, Bradshaw CS. Sexual risk factors and bacterial vaginosis: a systematic review and meta-analysis. Clin Infect Dis 2008;47:1426-1435.
115. Verstraelen H, Verhelst R, Vaneechoutte M, Temmerman M. The epidemiology of bacterial vaginosis in relation to sexual behaviour. BMC Infect Dis 2010;10:81.
116. Marrazzo JM, Koutsky LA, Eschenbach DA, Agnew K, Stine K, Hillier SL. Characterization of vaginal flora and bacterial vaginosis in women who have sex with women. J Infect Dis 2002;185:1307-1313.
117. Gray RH, Kigozi G, Serwadda D, Makumbi F, Nalugoda F, Watya S, et al. The effects of male circumcision on female partners' genital tract symptoms and vaginal infections in a randomized trial in Rakai, Uganda. Am J Obstet Gynecol 2009;200:42.e1-7.
118. Manhart LE, Khosropour CM, Liu C, Gillespie CW, Depner K, Fiedler T, et al. Bacterial vaginosis-associated bacteria in men: association of Leptotrichia/Sneathia spp. with nongonococcal urethritis. Sex Transm Dis 2013;40:944-949.
119. Cherpes TL, Hillier SL, Meyn LA, Busch JL, Krohn MA. A delicate balance: risk factors for acquisition of bacterial vaginosis include sexual activity, absence of hydrogen peroxide-producing lactobacilli, black race, and positive herpes simplex virus type 2 serology. Sex Transm Dis 2008;35:78-83.
120. Masese L, Baeten JM, Richardson BA, Bukusi E, John-Stewart G, Jaoko W, et al. Incident herpes simplex virus type 2 infection increases the risk of subsequent episodes of bacterial vaginosis. J Infect Dis 2014;209:1023-1027.
121. Martin DH, Zozaya M, Lillis RA, Myers L, Nsuami MJ, Ferris MJ. Unique vaginal microbiota that includes an unknown Mycoplasma-like organism is associated with Trichomonas vaginalis infection. J Infect Dis 2013;207:1922-1931.
122. Fichorova RN, Lee Y, Yamamoto HS, Takagi Y, Hayes GR, Goodman RP, et al. Endobiont viruses sensed by the human host: beyond conventional antiparasitic therapy. PLoS One 2012;7:e48418.
123. Colli E, Landoni M, Parazzini F. Treatment of male partners and recurrence of bacterial vaginosis: a randomised trial. Genitourin Med 1997;73:267-270.
124. Fethers KA, Fairley CK, Morton A, Hocking JS, Hopkins C, Kennedy LF, et al. Early sexual experiences and risk factors for bacterial vaginosis. J Infect Dis 2009;200:1662-1670.
125. Bump RC, Buesching WJ. Bacterial vaginosis in virginal and sexually active adolescent females: evidence against exclusive sexual transmission. Am J Obstet Gynecol 1988;158:935-939.
126. Yen S, Shafer M-A, Moncada J, Campbell CJ, Flinn SD, Boyer CB. Bacterial vaginosis in sexually experienced and nonsexually experienced young women entering the military. Obstet Gynecol 2003;102:927-933.
127. Jones FR, Miller G, Gadea N, Meza R, Leon S, Perez J, et al. Prevalence of bacterial vaginosis among young women in low-income populations of coastal Peru. Int J STD AIDS 2007;18:188-192.
128. Vaca M, Guadalupe I, Erazo S, Tinizaray K, Chico ME, Cooper PJ, Hay P. High prevalence of bacterial vaginosis in adolescent girls in a tropical area of Ecuador. BJOG 2009;117:225-228.
129. Schwebke JR. New concepts in the etiology of bacterial vaginosis. Curr Infect Dis Rep 2009;11:143-147.
130. Baeten JM, Hassan WM, Chohan V, Richardson BA, Mandaliya K, Ndinya-Achola JO, et al. Prospective study of correlates of vaginal Lactobacillus colonisation among high-risk HIV-1 seronegative women. Sex Transm Infect 2009;85:348-353.
131. Hilber AM, Francis SC, Chersich M, Scott P, Redmond S, Bender N, et al. Intravaginal practices, vaginal infections and HIV acquisition: systematic review and meta-analysis. PLoS One 2010;5:e9119.
132. Vodstrcil LA, Hocking JS, Law M, Walker S, Tabrizi SN, Fairley CK, et al. Hormonal contraception is associated with a reduced risk of bacterial vaginosis: a systematic review and meta-analysis. PLoS One 2013;8:e73055.
133. Polis CB, Curtis KM. Use of hormonal contraceptives and HIV acquisition in women: a systematic review of the epidemiological evidence. Lancet Infect Dis 2013;13:797-808.
134. Ness RB, Hillier S, Richter HE, Soper DE, Stamm C, Bass DC, et al. Can known risk factors explain racial differences in the occurrence of bacterial vaginosis? J Natl Med Assoc 2003;95:201-212.
135. Verstraelen H, Verhelst R, Claeys G, De Backer E, Temmerman M, Vaneechoutte M. Longitudinal analysis of the vaginal microflora in pregnancy suggests that L. crispatus promotes the stability of the normal vaginal microflora and that L. gasseri and/or L. iners are more conducive to the occurrence of abnormal vaginal microflora. BMC Microbiol 2009;9:116.
136. Sobel JD, Ferris D, Schwebke J, Nyirjesy P, Wiesenfeld HC, Peipert J. Suppressive antibacterial therapy with 0.75% metronidazole vaginal gel to prevent recurrent bacterial vaginosis. Am J Obstet Gynecol 2006;194:1283-1289.
137. McClelland RS, Richardson BA, Hassan WM, Chohan V, Lavreys L, Mandaliya K, et al. Improvement of vaginal health for Kenyan women at risk for acquisition of human immunodeficiency virus type 1: results of a randomized trial. J Infect Dis 2008;197:1361-1368.
138. FAO/WHO. Probiotics in food: Health and nutritional properties and guidelines for evaluation. Rome, 2006. ftp://ftp.fao.org/es/esn/food/wgreport2.pdf.
139. Senok AC, Verstraelen H, Temmerman M, Botta GA. Probiotics for the treatment of bacterial vaginosis. Cochrane Database Syst Rev 2009 CD006289.
140. Bradshaw CS, Pirotta M, De Guingand D, Hocking JS, Morton AN, Garland SM, et al. Efficacy of oral metronidazole with vaginal clindamycin or vaginal probiotic for bacterial vaginosis: randomised placebo-controlled double-blind trial. PLoS One 2012;7:e34540.
141. Dover SE, Aroutcheva AA, Faro S, Chikindas ML. Natural antimicrobials and their role in vaginal health: a short review. Int J Probiotics Prebiotics 2008;3:219-230.
142. Winberg J, Herthelius-Elman M, Möllby R, Nord C. Pathogenesis of urinary tract infection: experimental studies of vaginal resistance to colonization. Pediatric Nephrol 1993;7:509-514.
143. Brotman RM, Ghanem KG, Klebanoff MA, Taha TE, Scharfstein DO, Zenilman JM. The effect of vaginal douching cessation on bacterial vaginosis: a pilot study. Am J Obstet Gynecol 2008;198:628e1-7.
144. Marrazzo JM, Thomas KK, Ringwood K. A behavioural intervention to reduce persistence of bacterial vaginosis among women who report sex with women: results of a randomised trial. Sex Transm Infect 2011;87:399-405.